An OHSU kidney transplant patient recalls her medical experience, citing family and community support as influential to a successful health outcome.

The Catholic Sentinel reports on the OHSU Interprofessional Access Network’s work with Catholic Charities in Southeast Portland, where OHSU nursing students assist clients with complex needs. Kristen Beiers-Jones, R.N., M.S.N., describes how students help clients with their health needs as well as their social needs, including helping an Iraqi refugee fish again, adding: “I think they’ll forever be nurses with a heightened cultural humility after this term.” (pages F-G)

Story describes where and how Oregonians can get their COVID-19 vaccine.

OHSU contributed to a Diabetes Care paper that notes diets high in red and processed meats are associated with high risk of type 2 diabetes, cardiovascular disease, cancer and other conditions

Patrick DeMartino, M.D., discusses new research that projects that the associated cost of gene therapy to treat sickle cell anemia, would have considerable budget impacts for Medicaid.

Dawn Nolt, M.D., M.P.H., comments on new CDC guidance that relaxes physical distancing limits inside the classroom. She says: “We have more and more data to support this idea that this new guidance will be safe."

William Messer, M.D., Ph.D., says that, while it is still too soon to understand whether or not coronavirus will become an annual occurrence similar to cold and flu season, he is optimistic that growing rates of virus immunity will soon help to make caseloads and symptoms more manageable.

Christina Milano, M.D., notes adjusting hormones can help patients who experience changes in sexual function while receiving gender-affirming hormones.

Story covers results of phase 3 trial for acromegaly, a pituitary disorder. Maria Fleseriu, M.D., FACE, says: “As a practicing endocrinologist, I believe that these data provide valuable insights to physicians on the potential benefit of a twice daily oral drug versus long-acting injections for most patients."

The Kuni Foundation awards $2.5 million to OHSU for cancer research.